⌂
Home
◈
Markets
▦
Screener
📈
Tools
◎
Portfolio
Skip to content
DFM General
5,814.71
−0.34%
FTSE ADX
9,780.12
−0.50%
TASI
9,952.06
−1.69%
QE Index
8,598.42
−0.40%
S&P 500
7,712.57
+0.28%
Nasdaq 100
29,490.28
−0.13%
Nifty 50
22,822.95
−0.29%
Sensex
73,764.90
−0.12%
KSE-100
165,937.21
+0.48%
DFM:EMIRATESNBD
AED 31.72
+0.44%
ADX:IHC
AED 353.90
−0.76%
SAU:2222
SAR 25.48
−1.24%
DSMD:QNBK
QAR 15.55
−0.70%
NAS:NVDA
$216.47
−0.29%
NYSE:TSM
$425.08
+1.16%
NSE:RELIANCE
₹1,220.30
+1.52%
KAR:OGDC
Rs 300.25
+0.08%
Gold
$4,113.96
−0.28%
Brent
$110.31
+1.13%
BTC
$82,598.08
−0.42%
ETH
$2,435.57
−0.45%
DFM General
5,814.71
−0.34%
FTSE ADX
9,780.12
−0.50%
TASI
9,952.06
−1.69%
QE Index
8,598.42
−0.40%
S&P 500
7,712.57
+0.28%
Nasdaq 100
29,490.28
−0.13%
Nifty 50
22,822.95
−0.29%
Sensex
73,764.90
−0.12%
KSE-100
165,937.21
+0.48%
DFM:EMIRATESNBD
AED 31.72
+0.44%
ADX:IHC
AED 353.90
−0.76%
SAU:2222
SAR 25.48
−1.24%
DSMD:QNBK
QAR 15.55
−0.70%
NAS:NVDA
$216.47
−0.29%
NYSE:TSM
$425.08
+1.16%
NSE:RELIANCE
₹1,220.30
+1.52%
KAR:OGDC
Rs 300.25
+0.08%
Gold
$4,113.96
−0.28%
Brent
$110.31
+1.13%
BTC
$82,598.08
−0.42%
ETH
$2,435.57
−0.45%
☰
Markets
▼
Stock markets
🇦🇪
UAE
DFM · ADX · DFM General
Open
🇸🇦
Saudi Arabia
Tadawul · TASI
Closed
🇶🇦
Qatar
QSE · QE General
Closed
🇺🇸
United States
Nasdaq · NYSE · S&P 500
Closed
🇮🇳
India
NSE · BSE · Nifty 50
Open
🇵🇰
Pakistan
PSX · KSE-100
Open
Other assets
₿
Crypto
Ranked by volume · 24/7
🥇
Gold, FX & economy
Dubai gold, AED crosses, rates
◫
ETFs
Index, sector and gold funds
Explore
▦
Market map
Every market as a heatmap
📅
Calendar & IPOs
Earnings, dividends, listings, releases
⌁
Options flow · Ownership · Politics
US filings and tapes
Screener
▼
⚲
Stock screener
All six markets, one row per company
★
Ready-made screens
Starting points with a point of view
📁
My saved screens
Saved rules with alerts on new matches
⇄
Compare
Up to five, side by side
Crypto
Tools
▼
📈
Charting
Drawings, indicators, replay
▶
Strategy Maker
Write a rule, test it on history
⇄
Compare
Side by side
🔔
Alerts
Price, earnings, screens, strategies
News
Portfolio
⌕
AED
USD
SAR
QAR
INR
PKR
GBP
EUR
KWD
OMR
BHD
☆
♢
☾
Sign in
Create account
👤
Markets
›
United States
› NAS
› ACET
A
Adicet Bio Inc
NAS:ACET
Healthcare
nasdaq_composite
$4.52
−0.22%
At close
At close · Wed 21 Oct · ≈
AED 16.60
· Market cap
—
· Next earnings
Wed 4 Nov
☆
Watch
🔔
Alert
⇄
Compare
▶
Test a strategy
✦
AI read
Overview
Chart
Financials
Valuation
Forecasts
Dividends
Ownership
Options
Shorts
News
Profile
Adicet Bio Inc · News · TradingHolo
ACET news
Headlines tagged to this company
BU
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
BusinessWire · 20 d ago
DO
Adicet Bio Price Target Raised to $28.00/Share From $25.00 by Wedbush
Dow Jones Newswires · 22 d ago
TR
Wedbush maintains Outperform rating on Adicet Bio, $28 price target
TradingView · 22 d ago
QU
ACET: Prula-cel achieved high remission rates and robust immune reset in lupus with strong safety data
Quartr · 23 d ago
DO
Adicet Bio Is Maintained at Buy by HC Wainwright & Co.
Dow Jones Newswires · 23 d ago
TR
HC Wainwright & Co. maintains Buy rating on Adicet Bio, $34 price target
TradingView · 23 d ago
QU
ACET: Prula-cel achieved high remission rates and strong safety in lupus, advancing to pivotal trials
Quartr · 23 d ago
TR
Adicet reports positive Phase 1 prula-cel data; 54% DORIS, 50% CRR at 12 months, favorable safety
TradingView · 23 d ago
QU
ACET: Prula-cel achieved robust, durable remissions and immune reset in lupus patients with strong safety
Quartr · 23 d ago
QU
ACET: Prula-cel showed high remission rates and favorable safety in SLE, supporting pivotal trial plans
Quartr · 23 d ago
RE
Adicet Bio Announces Positive Safety And Efficacy Data From Prula-Cel (Formerly Adi-001) Study In Patients With Systemic Lupus Erythematosus With Or Without Lupus Nephritis
Reuters · 23 d ago
TR
Adicet Bio, Inc. (ACET) Reports Positive SLE/LN Phase 1 Data, Plans Pivotal LN Study Start-Up in Q4 2026
TradingView · 23 d ago
BU
Adicet Bio to Host Webcast to Present Prula-cel (formerly ADI-001) Clinical Data in Patients with Systemic Lupus Erythematosus with or without Lupus Nephritis
BusinessWire · 25 d ago
ZA
Wall Street Analysts Think Adicet Bio (ACET) Could Surge 301.57%: Read This Before Placing a Bet
Zacks Investment Research · 68 d ago
MA
Adicet Bio Eyes Key Lupus Data This Quarter for Off-the-Shelf Cell Therapy
MarketBeat · 71 d ago
ZA
All You Need to Know About Adicet Bio (ACET) Rating Upgrade to Buy
Zacks Investment Research · 72 d ago
End of the feed